Highbridge Capital Management’s Abeona Therapeutics Inc Warrant ABEOW Stock Holding History

Highbridge Capital Management’s Portfolio ABEOW Stock Details ABEOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-250,000	Closed	-$69K	–	88
2019 Q3	$69K	Hold	250,000	–	–	0.01%	74
2019 Q2	$255K	Hold	250,000	–	–	0.02%	150
2019 Q1	$835K	Hold	250,000	–	–	0.03%	282
2018 Q4	$788K	Hold	250,000	–	–	0.02%	278
2018 Q3	$1.98M	Hold	250,000	–	–	0.05%	333
2018 Q2	$2.67M	Hold	250,000	–	–	0.05%	349
2018 Q1	$2.43M	Hold	250,000	–	–	0.04%	415
2017 Q4	$2.73M	Hold	250,000	–	–	0.05%	343
2017 Q3	$3M	Buy	+250,000	New	+$1.66M	0.04%	369

Highbridge Capital Management's ABEOW Position: Q4 2019 in Review

Highbridge Capital Management sold out of Abeona Therapeutics Inc Warrant (ABEOW) in Q4 2019, closing a stake of 250,000 shares — an estimated $69K sold.

Highbridge Capital Management first reported a position in ABEOW in Q3 2017 and held it in 9 quarters. The position peaked at $3M in Q3 2017. 0 funds tracked by Wall St. Rank hold ABEOW as of Q4 2019.

Highbridge Capital Management reported no remaining Abeona Therapeutics Inc Warrant position as of Q4 2019 after selling out during the quarter.
Highbridge Capital Management sold 250,000 Abeona Therapeutics Inc Warrant shares in Q4 2019, an estimated $69K.
Highbridge Capital Management first reported a position in Abeona Therapeutics Inc Warrant in Q3 2017 and held it in 9 quarters.
Highbridge Capital Management's Abeona Therapeutics Inc Warrant position peaked at $3M in Q3 2017.
0 funds tracked by Wall St. Rank held Abeona Therapeutics Inc Warrant as of Q4 2019.

Based on Highbridge Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.